Kezhi Jiaonang (壳脂胶囊)壳脂胶囊
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 内蒙古福瑞医疗科技股份有限公司Chinese legal name: 内蒙古福瑞医疗科技股份有限公司
主要成分Active Ingredients
- 甲壳Jia Qiao
- 制何首乌Zhihe Shouwu
- 茵陈Yin Chen
- 丹参salvia
- 牛膝Niu Xi
药物知识说明
甲壳是一种在国家药监局注册认定的药品。该药品含有丹参、制何首乌、牛膝-6bdbd195等成分。
该药品关联的活性成分包括：丹参salvia、制何首乌Zhihe Shouwu、牛膝Niu Xi、茵陈Yin Chen。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：内蒙古福瑞医疗科技股份有限公司Chinese legal name: 内蒙古福瑞医疗科技股份有限公司。
您可以探索含有相同成分的其他药品：丹参-d5a58f0e成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 壳脂胶囊) is a medicine registered with the national drug regulatory authority. It contains salvia and other recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 丹参salvia, 制何首乌Zhihe Shouwu, 牛膝Niu Xi, 茵陈Yin Chen.
Manufacturers recorded for this product: 内蒙古福瑞医疗科技股份有限公司Chinese legal name: 内蒙古福瑞医疗科技股份有限公司.
Explore other medicines containing the same ingredient: 丹参 productssalvia products.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 壳脂胶囊Recorded Chinese name: 壳脂胶囊
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 0.25g*30粒0.25 g × 30 capsules
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 内蒙古福瑞医疗科技股份有限公司Chinese legal name: 内蒙古福瑞医疗科技股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字Z20050665
关联实体Relationships
相关问题Questions
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字Z20050665
Manufacturer
Chinese legal name: 内蒙古福瑞医疗科技股份有限公司 (domestically manufactured)
Traditional functions
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
0.25 g × 30 capsules
中文说明书原文Original Chinese source label
批准文号
国药准字Z20050665
生产企业
内蒙古福瑞医疗科技股份有限公司(国产)
功能主治
清化湿浊、活血散结、补益肝肾。用于治疗非酒精性脂肪肝湿浊内蕴、气滞血瘀或兼有肝肾不足郁热证，症见肝区闷胀不适或闷痛、耳鸣、胸闷气短、肢麻体重、腰膝酸软、口苦口粘、尿黄、舌质暗红、苔薄黄腻、脉或弦数或弦滑等。
用法用量
口服。一次5粒，每日3次。
不良反应
临床试验过程中，试验组有1例大便次数增多，每日2-3次，轻度，经判断可能与药物有关。
禁忌
1、妊娠及哺乳期妇女禁用。
2、对本药过敏者禁用。
注意事项
1、对于经检查证实由肾病、免疫性疾病、糖尿病引起的高脂血症脂肪肝患者，目前仍无临床试验资料。
2、建议服药过程中配合饮食控制(包括脂肪、酒精摄入等)。
贮藏
密封，避光，置阴凉干燥处。
规格
0.25g*30粒
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.